ArticleBioMed research international2016

The -174G/C Interleukin-6 Gene Promoter Polymorphism as a Genetic Marker of Differences in Therapeutic Response to Methotrexate and Leflunomide in Rheumatoid Arthritis.

A J Ruiz-Padilla et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.